Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testingHeidi J. Gray, Carla Grandori, Brady Bernard et al.|npj Precision Oncology|2023Cited by 26
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid CorrelatesDaniel A. King, Calvin J. Kuo, Amber R. Smith et al.|JCO Precision Oncology|2023Cited by 15
Predictive value of a CLIA-approved organoid based drug sensitivity test.Astrid Margossian, Carla Grandori, Annie Richardson et al.|Journal of Clinical Oncology|2020Cited by 6
A cancer organogram test as a guide for oncology treatments in SOLID tumors: An analysis of 628 tests in 419 patients.Astrid Margossian, Carla Grandori, Madison Pollastro et al.|Journal of Clinical Oncology|2021Cited by 4
Abstract 534: Functional drug screening of organoids from ovarian cancer patients demonstrates clinical and genomic concordance and identifies novel therapeutic vulnerabilitiesGoldie Y.L. Lui, Carla Grandori, Anne B. Richardson et al.|Cancer Research|2021Cited by 4